Status:
COMPLETED
Teta Burst Versus 10 Hz Repetitive Transcranial Magnetic Stimulation İn Neuropathic Pain: A Sham Controlled Comparison
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Neuropathic pain is a common complication after spinal cord injury (SCI), which significantly affects the patient's quality of life and may be resistant to pharmacological treatment. In our study, we ...
Detailed Description
Pharmacological treatments may be insufficient to limit neuropathic pain. Therefore, research continues for safe and effective new treatments. Transcranial magnetic stimulation (TMS) is a non-invasive...
Eligibility Criteria
Inclusion
- Between the ages of 18-65,
- Traumatic/Non-traumatic spinal cord injury (\>4 months),
- For \>3 months, despite pharmacological treatment (no dose or medication changes have been made for at least 1 month), Brief Pain Inventory (BPI)-Part 1 average pain score is ≥4/10, neuropathic pain at the injury level and/or below (DN4 ≥4 /10) patients
Exclusion
- Pain attributed to causes other than neuropathic pain (e.g. musculoskeletal pain, pain resulting from diabetic polyneuropathy), Having a history of epilepsy, dementia, cognitive impairment, neurodegenerative disease,
- Having a history of psychiatric illness (except reactive depression),
- Having a lesion in the brain due to vascular, traumatic, tumoral or infectious reasons,
- Having a history of alcoholism,
- Having an intracranial metallic implant,
- Having a cardiac pacemaker,
- Pregnant patients
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06197113
Start Date
July 1 2022
End Date
July 11 2023
Last Update
January 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye), 06800